Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies5
  • 7D-3.0%
  • 3M4.3%
  • 1Y-16.6%
  • YTDn/a

Last week, the Biotech industry hasn't moved much but Zealand Pharma is up 4.6% in that time. As for the longer term, the industry has declined 14% in the last year. Earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024kr.173.3bkr.23.9bkr.5.0b18.1x34.4x7.2x
Sun, 24 Mar 2024kr.193.4bkr.23.9bkr.5.0b19.8x38.5x8.1x
Tue, 20 Feb 2024kr.176.6bkr.22.8bkr.4.2b24.3x41.9x7.8x
Thu, 18 Jan 2024kr.170.6bkr.23.3bkr.4.2b23.7x41x7.3x
Sat, 16 Dec 2023kr.172.6bkr.23.3bkr.4.2b25.6x41.5x7.4x
Mon, 13 Nov 2023kr.168.3bkr.22.7bkr.4.3b21.3x39.2x7.4x
Wed, 11 Oct 2023kr.193.6bkr.22.0bkr.4.7b22.5x40.9x8.8x
Fri, 08 Sep 2023kr.198.7bkr.22.0bkr.4.7b23.1x42.1x9x
Sun, 06 Aug 2023kr.190.2bkr.20.6bkr.3.9b36.7x49.1x9.2x
Tue, 04 Jul 2023kr.198.8bkr.19.5bkr.4.4b40.5x45.1x10.2x
Thu, 01 Jun 2023kr.208.4bkr.19.5bkr.4.4b40.9x47.3x10.7x
Sat, 29 Apr 2023kr.209.6bkr.17.9bkr.4.1b32.8x51.2x11.7x
Mon, 27 Mar 2023kr.194.8bkr.17.9bkr.3.5b30.5x55x10.9x
Wed, 22 Feb 2023kr.210.7bkr.14.7bkr.3.3b32x64.4x14.3x
Fri, 20 Jan 2023kr.206.4bkr.14.7bkr.3.3b31.3x63.1x14x
Sun, 18 Dec 2022kr.225.3bkr.14.7bkr.3.3b35.3x68.8x15.3x
Tue, 15 Nov 2022kr.227.7bkr.14.7bkr.3.3b35.1x69.6x15.5x
Thu, 13 Oct 2022kr.204.6bkr.12.4bkr.1.5b45.4x134.7x16.5x
Sat, 10 Sep 2022kr.206.0bkr.12.4bkr.1.5b45.7x138.4x16.6x
Mon, 08 Aug 2022kr.201.3bkr.11.1bkr.130.5m70.3x1543x18.2x
Wed, 06 Jul 2022kr.179.4bkr.11.1bkr.130.5m66.2x1374.8x16.2x
Fri, 03 Jun 2022kr.154.6bkr.11.0b-kr.88,588,000.0057.4x-1745.6x14x
Sun, 01 May 2022kr.177.5bkr.10.7bkr.622.4m54.5x285.2x16.6x
Tue, 29 Mar 2022kr.174.5bkr.10.7bkr.625.7m52.5x278.9x16.3x
Thu, 24 Feb 2022kr.150.9bkr.10.4bkr.252.9m44.8x596.8x14.5x
Sat, 22 Jan 2022kr.167.8bkr.9.8bkr.117.9m50.9x1422.9x17.1x
Mon, 20 Dec 2021kr.187.5bkr.9.8bkr.117.9m56.2x1590.1x19.1x
Wed, 17 Nov 2021kr.205.7bkr.9.8bkr.112.0m61.7x1837.3x20.9x
Fri, 15 Oct 2021kr.214.4bkr.9.3b-kr.169,922,000.0072.9x-1261.7x23x
Sun, 12 Sep 2021kr.214.7bkr.9.3b-kr.169,922,000.0072.4x-1263.6x23.1x
Tue, 10 Aug 2021kr.215.6bkr.9.3b-kr.169,922,000.0074.7x-1269x23.2x
Mon, 03 May 2021kr.178.6bkr.13.2bkr.3.5b26.6x50.9x13.5x
Price to Earnings Ratio

50.9x


Total Market Cap: kr.178.6bTotal Earnings: kr.3.5bTotal Revenue: kr.13.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 78.6x202220232024
Current Industry PE
  • Investors are pessimistic on the Danish Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 35.5x which is lower than its 3-year average PE of 78.7x.
  • The 3-year average PS ratio of 14.2x is higher than the industry's current PS ratio of 7.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have grown 13% per year over the last three years.
  • Revenues for these companies have grown 22% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Danish Biotech compare with similar industries?

DK Market-0.0041%
Healthcare0.13%
Biotech-2.95%
Biotech-2.95%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand Pharmakr.599.000.2%
+kr.62.3m
165.5%PS108.8x
ORPHA Orphazymekr.1.10k0.02%
+kr.7.1k
0%PB2.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BAVA

kr.144.15

Bavarian Nordic

7D

-1.8%

1Y

-22.0%

BIOPOR

kr.1.23

BioPorto

7D

-1.6%

1Y

-17.8%

GMAB

kr.1,915.50

Genmab

7D

-4.0%

1Y

-30.5%

ZEAL

kr.599.00

Zealand Pharma

7D

0.2%

1Y

165.5%

ORPHA

kr.1,100.00

Orphazyme

7D

0.02%

1Y

0%